Salix and Medis have signed a long-term production and distribution agreement for a new product in the therapeutic area of digestive health

Monte di Malo, March 2022 – SALIX srl – a company with a legal entity and production site located in Monte di Malo (Vicenza), Italy that develops and produces medical devices, food supplements and food supplements for special medical purposes for the pharmaceutical companies and mass market in Italy and internationally – has signed an exclusive agreement with Medis, a pioneer in full-service pharmaceutical distribution in the region CEE. Under the agreement, Medis’ Consumer Health business unit is responsible for registering, distribution and marketing the new digestive health product in 11 markets – Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Hungary, Latvia, Lithuania, Northern Macedonia, Serbia and Slovenia.

“We value long-term partnerships and are pleased to work with one of the global leading manufacturers of food supplements and medical devices“,  said Martina Perharič, CEO of Medis. “I am confident that the commercialization of the new product – due to its unique and innovative formulation – will strengthen our position in the digestive health segment throughout the CEE region.” 

“We are very proud about this agreement and partnership with Medis, an important company recognized at international level,” said Linda Masello, CEO of Salix, emphasizing that: “The partnership with Medis is the result of our research and innovation capability and part of our long-term strategy to be a reference partner for international companies.”

About SALIX

Salix, located in Monte di Malo (Vicenza) – Italy, is active since 1999 and it is focused on the research, development and production of medical devices, food supplements, food supplements for special medical purposes. The production site, recently enlarged and renewed with new technologies and production lines, makes Salix at forefront for the production of solid and liquid dosage forms according to the highest international standards.

About Medis

With more than 30 years of experience, Medis is a recognized as a commercialization partner of choice for global pharmaceutical and biotechnology companies in the CEE region. By leveraging its marketing know-how, scientific expertise and product knowledge, Medis strives to make advanced medical treatments accessible to every patient in this region. Medis maintains its own subsidiaries in 17 countries and offers a full range of services to its partners. More information about Medis: www.medis.com and LinkedIn.